Stockscreener 앱 받기
9.71
2.02%
-0.20
시간 외 거래:
9.64
-0.07
-0.72%
Ginkgo Bioworks Holdings Inc 주식(DNA)의 최신 뉴스
ProQR forms advisory board, partnership with Ginkgo as part of AI strategy - MSN
MSN Money - MSN
DNA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation - 富途牛牛
DNA Stock Price, Quote & Chart | GINKGO BIOWORKS HOLDINGS INC (NYSE:DNA) - ChartMill
Ginkgo Bioworks (NYSE:DNA) Stock Price Up 11.1%What's Next? - MarketBeat
Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure - Quantisnow
Ginkgo Bioworks will take investor questions after May 7 results - Stock Titan
Will Ginkgo Bioworks Holdings (NYSE:DNA) Spend Its Cash Wisely? - Sahm
[ARS] Ginkgo Bioworks Holdings, Inc. SEC Filing - Stock Titan
Ginkgo Bioworks (NYSE: DNA) sets 2026 virtual meeting, auditor and pay votes - Stock Titan
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN
Ginkgo Bioworks Holdings, Inc. (DNA) stock drops despite market gains: Important facts to note - MSN
Ginkgo Bioworks Holdings, Inc. (DNA) increases despite market slip: Here's what you need to know - MSN
Price-Driven Insight from (DNA) for Rule-Based Strategy - Stock Traders Daily
Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed Against Ginkgo Bioworks Holdings, Inc. (DNA) and Encourages Investors with Significant Losses to Contact the Firm - TMX Newsfile
DNA Technical Analysis | Trend, Signals & Chart Patterns | GINKGO BIOWORKS HOLDINGS INC (NYSE:DNA) - ChartMill
Ginkgo Bioworks Divests Biosecurity Unit, Refocuses Core Operations - TipRanks
Ginkgo Bioworks (NYSE:DNA) Trading 6.9% HigherHere's What Happened - MarketBeat
Ginkgo Bioworks CFO Steven Coen sells $2,576 in shares By Investing.com - Investing.com India
Ginkgo Bioworks CFO Steven Coen sells $2,576 in shares - Investing.com
Ginkgo Bioworks (NYSE: DNA) officer sells shares to cover taxes after RSU vesting - Stock Titan
DNA (NYSE: DNA) Form 144: Proposed sale of 324 Class A shares, insider sales listed - Stock Titan
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating the Biotech Sector with a Potential 9% Upside - DirectorsTalk Interviews
(DNA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
DNA (NYSE: DNA) Rule 144 shows insider resale notices totaling tens of thousands of shares - Stock Titan
Short Interest in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Decreases By 23.2% - MarketBeat
Is Ginkgo Bioworks Holdings (NYSE:DNA) In A Good Position To Deliver On Growth Plans? - Moomoo
Steven Coen Sells 33,171 Shares of Ginkgo Bioworks (NYSE:DNA) Stock - MarketBeat
Ginkgo Bioworks CFO Coen sells $212k in shares By Investing.com - Investing.com South Africa
Ginkgo Bioworks CFO Coen sells $212k in shares - Investing.com
Ginkgo Bioworks (NYSE: DNA) CFO nets PSU shares, sells stock for taxes - Stock Titan
Ginkgo Bioworks (DNA) major shareholder sells $802k in stock By Investing.com - Investing.com South Africa
Ginkgo Bioworks (DNA) major shareholder sells $802k in stock - Investing.com
Ginkgo Bioworks (NYSE:DNA) Major Shareholder Barry Canton Sells 124,727 Shares - MarketBeat
PSU vesting drives tax share sale for Ginkgo Bioworks (DNA) holder - Stock Titan
Reshma Shetty of Ginkgo Bioworks (DNA) sells shares to cover tax after PSU vesting - Stock Titan
DNA (NYSE: DNA) files Form 144: 33,171 Class A shares tied to vesting - Stock Titan
Proposed Class A sale by DNA (NYSE: DNA) — Form 144 lists 40,893 shares - Stock Titan
Ginkgo Bioworks Announces Date of Second Quarter 2024 Results Pr - GuruFocus
0.14%
0.48%
자본화:
|
볼륨(24시간):